Management of Decompensated Chronic Liver Disease

Core Management Strategy

The American Association for the Study of Liver Diseases recommends that the management of decompensated chronic liver disease must prioritize immediate treatment of the underlying etiology, as this is the single most important intervention associated with decreased risk of further decompensation and increased survival 1
Etiological treatment must be initiated immediately upon diagnosis, as this directly impacts mortality and morbidity, with the effectiveness varying by etiology, such as alcoholic cirrhosis, hepatitis B, hepatitis C, and autoimmune hepatitis 1, 2, 3, 4

The European Association for the Study of the Liver recommends first-line treatment for ascites consisting of sodium restriction (<5 g/day) plus spironolactone with or without furosemide, with fluid restriction being unnecessary unless serum sodium drops below 120-125 mmol/L 1, 4
The American College of Gastroenterology recommends initiating vasoactive drugs immediately upon suspicion of variceal bleeding, even before endoscopic confirmation, with antibiotic prophylaxis being mandatory 1, 4
Lactulose is first-line therapy for hepatic encephalopathy, as it reduces mortality and prevents recurrent overt hepatic encephalopathy 1

Non-selective beta-blockers, such as propranolol, decrease the risk of ascites, hepatorenal syndrome, spontaneous bacterial peritonitis, and hepatic encephalopathy beyond variceal bleeding prevention, specifically in patients who achieve marked portal pressure reduction 1, 2
Anticoagulation with enoxaparin may delay hepatic decompensation and improve survival in patients with Child-Pugh scores 7-10 by preventing portal vein thrombosis and reducing intestinal barrier damage 1, 3

Sodium restriction to <5 g/day is recommended for ascites control, but excessive restriction should be avoided to prevent worsening malnutrition, with rapid nutritional screening being performed in all patients 4

Early referral for liver transplantation evaluation is essential for appropriate candidates, as decompensation significantly worsens prognosis, with mean pulmonary arterial pressure ≥45 mmHg being an absolute contraindication to liver transplantation 1

Remote monitoring technologies, such as Bluetooth-linked weighing scales and smartphone apps, may enable early intervention for weight changes, potentially improving outcomes and reducing hospital readmissions 3, 4
Heart rate variability monitoring may identify patients at risk of further decompensation 3, 4